First Time Loading...

Aspira Women's Health Inc
NASDAQ:AWH

Watchlist Manager
Aspira Women's Health Inc Logo
Aspira Women's Health Inc
NASDAQ:AWH
Watchlist
Price: 3.49 USD -1.13% Market Closed
Updated: Apr 20, 2024

Intrinsic Value

AWH's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. [ Read More ]

The intrinsic value of one AWH stock under the Base Case scenario is 10.97 USD. Compared to the current market price of 3.49 USD, Aspira Women's Health Inc is Undervalued by 68%.

Key Points:
AWH Intrinsic Value
Base Case
10.97 USD
Undervaluation 68%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Aspira Women's Health Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling AWH stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Aspira Women's Health Inc

Provide an overview of the primary business activities
of Aspira Women's Health Inc.

What unique competitive advantages
does Aspira Women's Health Inc hold over its rivals?

What risks and challenges
does Aspira Women's Health Inc face in the near future?

Has there been any significant insider trading activity
in Aspira Women's Health Inc recently?

Summarize the latest earnings call
of Aspira Women's Health Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Aspira Women's Health Inc.

Provide P/S
for Aspira Women's Health Inc.

Provide P/E
for Aspira Women's Health Inc.

Provide P/OCF
for Aspira Women's Health Inc.

Provide P/FCFE
for Aspira Women's Health Inc.

Provide P/B
for Aspira Women's Health Inc.

Provide EV/S
for Aspira Women's Health Inc.

Provide EV/GP
for Aspira Women's Health Inc.

Provide EV/EBITDA
for Aspira Women's Health Inc.

Provide EV/EBIT
for Aspira Women's Health Inc.

Provide EV/OCF
for Aspira Women's Health Inc.

Provide EV/FCFF
for Aspira Women's Health Inc.

Provide EV/IC
for Aspira Women's Health Inc.

Show me price targets
for Aspira Women's Health Inc made by professional analysts.

What are the Revenue projections
for Aspira Women's Health Inc?

How accurate were the past Revenue estimates
for Aspira Women's Health Inc?

What are the Net Income projections
for Aspira Women's Health Inc?

How accurate were the past Net Income estimates
for Aspira Women's Health Inc?

What are the EPS projections
for Aspira Women's Health Inc?

How accurate were the past EPS estimates
for Aspira Women's Health Inc?

What are the EBIT projections
for Aspira Women's Health Inc?

How accurate were the past EBIT estimates
for Aspira Women's Health Inc?

Compare the revenue forecasts
for Aspira Women's Health Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Aspira Women's Health Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Aspira Women's Health Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Aspira Women's Health Inc compared to its peers.

Compare the P/E ratios
of Aspira Women's Health Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Aspira Women's Health Inc with its peers.

Analyze the financial leverage
of Aspira Women's Health Inc compared to its main competitors.

Show all profitability ratios
for Aspira Women's Health Inc.

Provide ROE
for Aspira Women's Health Inc.

Provide ROA
for Aspira Women's Health Inc.

Provide ROIC
for Aspira Women's Health Inc.

Provide ROCE
for Aspira Women's Health Inc.

Provide Gross Margin
for Aspira Women's Health Inc.

Provide Operating Margin
for Aspira Women's Health Inc.

Provide Net Margin
for Aspira Women's Health Inc.

Provide FCF Margin
for Aspira Women's Health Inc.

Show all solvency ratios
for Aspira Women's Health Inc.

Provide D/E Ratio
for Aspira Women's Health Inc.

Provide D/A Ratio
for Aspira Women's Health Inc.

Provide Interest Coverage Ratio
for Aspira Women's Health Inc.

Provide Altman Z-Score Ratio
for Aspira Women's Health Inc.

Provide Quick Ratio
for Aspira Women's Health Inc.

Provide Current Ratio
for Aspira Women's Health Inc.

Provide Cash Ratio
for Aspira Women's Health Inc.

What is the historical Revenue growth
over the last 5 years for Aspira Women's Health Inc?

What is the historical Net Income growth
over the last 5 years for Aspira Women's Health Inc?

What is the current Free Cash Flow
of Aspira Women's Health Inc?

Financials

Balance Sheet Decomposition
Aspira Women's Health Inc

Current Assets 5.3m
Cash & Short-Term Investments 2.6m
Receivables 1.5m
Other Current Assets 1.2m
Non-Current Assets 982k
PP&E 693k
Other Non-Current Assets 289k
Current Liabilities 5.1m
Accounts Payable 1.3m
Accrued Liabilities 3m
Short-Term Debt 670k
Other Current Liabilities 166k
Non-Current Liabilities 3.5m
Long-Term Debt 1.4m
Other Non-Current Liabilities 2.1m
Efficiency

Earnings Waterfall
Aspira Women's Health Inc

Revenue
9.2m USD
Cost of Revenue
-3.9m USD
Gross Profit
5.3m USD
Operating Expenses
-24.1m USD
Operating Income
-18.9m USD
Other Expenses
2.2m USD
Net Income
-16.7m USD

Free Cash Flow Analysis
Aspira Women's Health Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

AWH Profitability Score
Profitability Due Diligence

Aspira Women's Health Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Positive Gross Profit
Exceptional 3-Years Revenue Growth
ROIC is Increasing
28/100
Profitability
Score

Aspira Women's Health Inc's profitability score is 28/100. The higher the profitability score, the more profitable the company is.

AWH Solvency Score
Solvency Due Diligence

Aspira Women's Health Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Short-Term Solvency
Long-Term Solvency
35/100
Solvency
Score

Aspira Women's Health Inc's solvency score is 35/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AWH Price Targets Summary
Aspira Women's Health Inc

Wall Street analysts forecast AWH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AWH is 5.36 USD with a low forecast of 3.33 USD and a high forecast of 7.56 USD.

Lowest
Price Target
3.33 USD
4% Downside
Average
Price Target
5.36 USD
53% Upside
Highest
Price Target
7.56 USD
117% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

AWH Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

AWH Price
Aspira Women's Health Inc

1M 1M
+0%
6M 6M
-40%
1Y 1Y
-36%
3Y 3Y
-96%
5Y 5Y
-82%
10Y 10Y
-92%
Annual Price Range
3.49
52w Low
2.4
52w High
6.13
Price Metrics
Average Annual Return 120.93%
Standard Deviation of Annual Returns 369.17%
Max Drawdown -98%
Shares Statistics
Market Capitalization 37.2m USD
Shares Outstanding 10 336 800
Percentage of Shares Shorted 1.5%

AWH Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Aspira Women's Health Inc Logo
Aspira Women's Health Inc

Country

United States of America

Industry

Health Care

Market Cap

37.2m USD

Dividend Yield

0%

Description

Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. The company is headquartered in Austin, Texas and currently employs 106 full-time employees. The company went IPO on 2000-09-29. Its products include OVA1 and Overa, OVA1plus, Aspira GenetiX and Aspira Synergy. OVA1 is a blood test that is intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass for which surgery is planned when the physician’s independent clinical, and Overa is intended to maintain OVA1’s high sensitivity. OVA1plus is a reflex test performed for those OVA1 test results that are in the intermediate risk range. Aspira GenetiX is a genetic test for gynecologic cancer risk, with a focus on female reproductive cancers, including breast, ovarian, endometrial, uterine and cervical cancers. Aspira Synergy is an en-suite, cloud-based technology transfer solution that provides an end-to-end solution from specimen collection to a customized white-label report for clinical laboratories to internalize testing of its products.

Contact

TEXAS
Austin
Suite 100, 12117 Bee Caves Road Building Three
+15125190400.0
https://aspirawh.com/

IPO

2000-09-29

Employees

106

Officers

President, CEO & Director
Ms. Nicole Sandford CPA
General Counsel & Corporate Secretary
Ms. Minh Merchant
Senior VP & CFO
Dr. Torsten Hombeck Ph.D.
Senior Vice President of Commercial Strategy & Operations
Ms. Michelle Snider

See Also

Discover More
What is the Intrinsic Value of one AWH stock?

The intrinsic value of one AWH stock under the Base Case scenario is 10.97 USD.

Is AWH stock undervalued or overvalued?

Compared to the current market price of 3.49 USD, Aspira Women's Health Inc is Undervalued by 68%.